| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8381805eba6d034fc77bd230dd02e6e2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-32434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-32422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-10 |
| filingDate |
1984-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7cafb8b2f1a55f9571cb36d26976344
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ed58f4b85a83e726d3c423183e3b018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbd5f7c08f94094f81aec43825178291
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52687f9f4122ccd6e7407038eda3235b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2f62fa317935adf3dd6321fb3dff29a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dad783aa642e02c84300471f85b7e65 |
| publicationDate |
1985-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0162054-A1 |
| titleOfInvention |
PRODUCTION OF cDNA REPRESENTING SEQUENCES OF THE HEPATITIS A VIRUS |
| abstract |
Hepatitis A virus cDNA production processes, related products and their uses. Hepatitis A virus cDNA is produced, for example, by reverse transcribing hepatitis A virus RNA and subsequently inserting viral cDNA into bacterial plasmids by genetic engineering techniques . The bacteria thus transformed are then cloned and cultured to produce replicas of chimeric plasmids containing the cDNA of the hepatitis A virus. This viral cDNA is useful in the screening tests for the hepatitis A virus and in the production of l antigen of this virus, as well as in the production of antibodies against the hepatitis A virus. |
| priorityDate |
1983-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |